Abstract-Plasma leptm concentration IS increased m hypertensive obese humans, but whether leptm contributes to the increased arterial pressure m obesity 1s not known
I
ncreased clrculatmg leptm, the peptlde product of the "obese gene,"' has been suggested to contribute to increased blood pressure m obesity by actlvatlon of the sympathetic nervous system ' Leptm production 1s increased m obese animals and humans and correlates posltlvely with body mass index 3 Because leptm binding sites have been found m regons of the brain that are also important m cardiovascular control,4 there 1s reason to suspect that leptm could affect cardiovascular function through its CNS effects Supporting this posslblhty 1s the observation by Haynes and colleagues,5 who recently demonstrated that acute intravenous (IV) infusion of leptm increased sympathetic nerve actlvlty to the kidney, the adrenal, and the brown adipose tissue m anesthetized Sprague-Dawley rats However, leptm has also been shown to cause natnuresls and dluresls followmg bolus IV infusion ' Thus, leptm may have multiple actions on the SNS and the kidney that, m some circumstances, could have opposite effects on artenal pressure regulation Moreover, it 1s not known which of these effects, If any, can be sustained and exert long-term effects on cardiovascular and renal function
The aim of this study, therefore, was to determine whether increases m circulating leptm, to levels similar to those found m obesity, cause sustained changes m cardiovascular, renal, and neurohumoral function. Furthermore, we investigated the role of CNS versus systemic mechanisms by comparmg the chronic effects of carotid artery and IV leptm mfuslon on control of arterial pressure and renal function Experimental Protocol
After 7 days of control measurements, murme leptm (Amgen Inc ) was infused mto the carotid arteries or femoral vem at 0 1 &g/kg/mm for 5 days and at 1 pg/kg/mm for 7 days, followed by a 7-day recovery penod Mean arterial pressure (MAP), heart rate (HR), urine volume, urinary sochum excretion, and food and water intake were recorded dally Blood samples (2 mL) were collected on the fifth day of the control, leptm mfuslon, and recovery periods for the measurement of plasma msuhn, leptm, aldosterone, cortlcosterone and protein concentration, blood glucose, hematocnt, PRA, GFR, and RPF The blood sample was replaced with an equal volume of saline Figure   1 . Effect of chronic bilateral carotid artery or Intravenous infuslon of leptln at 0 1 pg/kg/mln (5 days) and 1 0 pg/kg/min (7 days) on dally food intake In conscious normal SD rats (n=5 per group). l P<.O5 compared to control tlon) GFR and RPF were measured by usmg a 4-hour fasted plasma sample followmg a 24-hour IV infusion of '251-lothalamate (Glofil) and '3'I-todohlppuran, respectively Steady state 1s achieved after 24 hours of IV isotope mfuslon m this protocol, therefore, urinary excretion rate 1s equal to mfusion rate of the isotope, and the mfuslon rate of isotope can be subseltuted Food intake did not change significantly dunng leptm mfuslon at 0 1 pg/kg/mm However, at the higher infusion rate (1 Fg/kg/mm), food intake decreased markedly from 20 420 7 g/d to 7 120 5 g/d (Fig 1) Slmllar to the effect of carotid artery mfuslon, chronic IV mfuslon of leptm did not affect food intake at the low dose but markedly decreased food intake from 20 420 2 g/d to 6 220 5 g/d at 1 pg/kg/mm (Fig 1) Food intake m both carotid artery and IV mfuslon groups returned to control 2 days after leptm mfuslon was stopped MAP Increased slightly by day 5 of carotid artery leptm mfuslon at 0 1 pg/kg/mm, but the increase was not statistically significant (Fig 2) Figure  2 . Effect of chronrc bilateral carotrd artery or rntravenous rnfusron of leptrn at 0 1 pg/kg/mrn (5 days) and 1 0 pg/kg/min (7 days) on mean arterial pressure in conscrous normal SD rats (n=5 per group) *PC 05 compared to control decreased rapidly to levels below control levels after leptm mfuslon was stopped m both carotid artery and IV infusion groups Chronic carotid artery mfuslon of leptm at 0 1 pg/kg/mm did not change heart rate slgmficantly, but at the 1 pg/kg/mm dose, HR increased from 32354 beats/mm to 355?5 beats/ mm by day 7 of the infusion (Fig 3) carotid artery mfuslon, chrome IV mfuslon of leptm did not affect HR at the low dose, but heart rate increased slgmficantly at the high dose, from 30529 beats/mm durmg the control period to 322210 beats/mm by day 7 of the leptm mfuslon period (Fig 3) HR decreased rapidly m both carotid artery and IV mfuslon groups after leptm mfuslon was stopped and was significantly below control (302+5 beats/mm and 28425 beats/mm, respectively) by day 3 of the recovery period Effects of Leptin Infusion on Renal Function Although there was a tendency for unne volume to increase during lephn mfuslon at 1 pg/kg/mm in both carohd artery and IV mfislon groups, the increase was not stahstlcally significant (Fig  4) There also was no slgmficant change m unnary sodium excrenon m either group durmg leptm mfislon at 0 1 or 1 pg/kg/rmn (Fig 5) carotid artery leptm mfiislon at either dose (Fig 6) , but m the IV mfuslon group, RPF decreased ngmficantly and RVR increased slgmficantly at the m!&on rate of 1 kg/kg/mm (Fig 6) Leptm mf&lon at 1 pg/kg/mm m both carotid and IV mfuslon groups markedly decreased potassium excreoon, parallehng the decrease m food intake and potassium Intake, since the food contained all of the dally potassium intake This resulted m a negaove cumulative potassnnn balance of -6.2-+0 4 mEq and -7 Ok1 0 mEq m the carohd and IV mfuslon groups, respecnvely, after 12 days of leptm mf&on After stopping leptm m&on for 7 days, there was still a negative cumulative potassium balance of -3 8+0 8 mEq and -6 1 213 mEq m the carotid and IV mf&on groups, respectively
Effects of Leptin Infusion on Circulating Hormones
Plasma leptm concentration did not change slgmficantly at the infusion rate of 0 1 pg/kg/mm m either the carotid artery or the IV mfuslon group but increased slgmficantly at 1 kg/kg/nun, from 12-+0 4 to 91?5 ng/mL m the carood artery mf&on group (Table 1) and f?om 0 9+0 1 to 9429 ng/mL m the IV mfuslon group (Table 2 ) Blood glucose and msuhn levels also &d not change at the low m&on rate m either the carotid artery or the IV mfislon group but decreased slgmficantly at 1 pg/kg/mm m both groups Plasma leptm, msuhn, and blood glucose returned to control levels atier leptm mf&on was stopped m both groups There were no ngmficant changes m PRA, plasma aldosterone, or cortlcosterone concentraoons dunng leptm mfuslon m either group (Table 1 and 2)
Discussion
The most significant finding of this study 1s that chrome leptm mfuslon, at rates that increased plasma leptm concentrations to levels comparable to those found m obese humans, markedly reduced food intake and elevated artenal pressure and heart rate m normal rats The tendency for arterial pressure to increase only m the carotid artery mfuslon group at the low dose 1s consistent with the posslblhty that the pressor effect of leptm may have a CNS component However, the higher mfuslon rate produced similar increases m both plasma levels of leptm and artenal pressure
Humoral and Metabolic Actions of Leptin
Food intake did not change dunng carotid artery or IV leptm mfuslon at 0 1 pg/kg/mm but was decreased slgmficantly at 1 pg/kg/mm m both groups These observations are consistent with previous studies that chronic mJectlon of leptm m ob/ob mice, animals with deficient leptm production, slgmficantly reduces food intake 'l-l3 The mechanism for leptm's effect to reduce food intake has been suggested to be suppression of hypothalamic NPY mRNA expression and NPY release," although most previous studies have used very high concentrations of leptm to demonstrate these effects In the present study, increased clrculatmg leptm concentration, to levels comparable to those found m obese humans,3 markedly reduced food intake These observation provide further support for the concept that leptm 1s an important physlolog& regulator of energy balance Increased clrculatmg leptm also markedly decreased plasma msuhn concentration and modestly reduced blood glucose Although the mechamsms responsible for leptm's effects on plasma msuhn and glucose levels are not clear, a recent study by Kleffer et a1'5 indicates that there are leptm receptors located on the pancreatic p-cells, although the function of these receptors Values are mean?SE, n=5 rats *P<O 05 compared with control, leptin (0 1 pglkglmm), and recovery Values are mean%SE, n=5 rats *f<O 05 compared with control, leptln (0 1 pg/kg/mm), and recovery 1s not known Leptm may also decrease msuhn release by stimulating a-adrenerglc receptors m the pancreas via its effect on sympathetic activity However, the finding that leptm decreased plasma glucose suggests addmonal effects besides a simple mhlbltlon of msuhn secretion Another posslblhty 1s that leptm increased glucose utlhzatlon or improved msuhn sensltlvlty m peripheral tissues, which enhanced glucose dlsposal m skeletal muscle and fat cells and suppressed glucose output by the liver Thus, the decrease m plasma msuhn could be a compensatory response to a fall m plasma glucose Addmonal studies are needed, however, to determine how leptm affects glucose control and insulin secretion Leptm, at the higher dose, did not alter plasma remn acnvlty, but cortlcosterone and aldosterone tended to decrease, although not significantly
The reduced plasma aldosterone levels may be related to reduced potassium Intake associated with reduced food consumption Arterial Pressure and Heart Rate Responses to Leptin Previous studles5~6~'6 have reported that arterial pressure and heart rate were not changed by acute leptm mfuslon One possible explanation 1s that arterial pressure and heart rate were measured under anesthesia m those studies, whereas our studies were conducted m conscious rats In addmon, leptm was administered acutely m previous studies, either by a single bolus inJection or by short-term infusion Our results are consistent with those findings, because the increases m artenal pressure and heart rate were not apparent until 3 to 4 days after the leptm infusion was started This was true even for the low infusion rate, which appeared to have a small centrally medlated effect on artenal pressure, smce there was no significant change m systemic plasma leptm concentration and IV leptm infusion at this rate caused no changes m heart rate and artenal pressure Thus, both the arterial pressure and heart rate responses to physlologlcal increases m clrculatmg leptm levels appear to be slow m onset
The mechanisms by which increased circulating levels of leptm elevate arterial pressure and heart rate chronically are not entirely clear One possible explanation 1s activation of the sympathetic nervous system The finding that animals with deficient leptm production (ob/ob mice) or defective leptm receptors (db/db mice) also have decreased metabohc activity and hypothermia 1s consistent with the concept that leptm mteracts with hypothalamic receptors to reduce food intake and activate the SNS ' Furthermore, leptm has been shown to increase norepmephnne turnover m mterscapular brown ad]-pose tissue," and a recent study by Haynes and colleagues5 reported that acute IV mfuslon of leptm m rats increased sympathetic nerve activity m the adrenals, brown adipose tissue, and the kidneys Our finding that there was a tendency for arterial pressure to increase with low-dose carotid artery mfuslon suggests a possible CNS mechanism, but our studies cannot determme the precise role of CNS compared to systemic actions of leptm m chronic blood pressure regulation
Further studies are needed to determine the role of the CNS and penpheral effects of leptm m long-term blood pressure regulation Heart rate also increased slgmficantly with chronic carotid artery and IV leptm mfuslon at 1 pg/kg/mm Although leptm receptor mRNA has been shown to be expressed m the heart,' the physlologcal role of this receptor remains to be determined Leptm could increase heart rate by increasing Lardlac sympathetic activity or by withdrawal of parasympathetic tone A recent study m our laboratory, for example, demonstrated that the increased heart rate associated with 5 weeks of a high-fat &et m dogs was due mamly to decreased chohnergc activity " However, additional studies are required to determme the contrlbutlon of sympathetic and parasympathetic mechanisms m mediating leptm's effect on heart rate Renal E#xts of Leptin Previous acute studies have shown that mfuslon of leptm at high doses caused natnuresls and dmresls ' " For example, Jackson and L16 reported that mtrarenal leptm mJectlon at 30 Fg/mm caused a twofold increase m urine volume and sodmm excretion m normal rats Reams et al'" also reported that bolus IV mjectlon of leptm at 400 pg/kg slgmficantly Increased unne volume and sodium excretion m normotenslve SpragueDawley rats, although natrmresls was not observed m spontaneously hypertensive rats
In the present study, we found no significant changes m sodium excretion or urine volume during chrome mfuslon of leptm at a rate that produced physlologcal increases m plasma leptm concentration However, the absence of significant changes m sodium excretion m our study does not necessary imply that leptm had no effect on renal function In fact, IV leptm infusion slgmficantly decreased RPF and increased RVR Moreover, the observation that leptm did not increase sodium excretion, despite ralsmg arterial pressure, provides evidence that leptm, infused IV or via the carotid arteries, shifted the renal-pressure natnuresls relationship to higher
